Injury & Recovery
Body-area terms help discovery; evidence remains tied to the actual population, route and endpoint studied.
How to read this page
Topic and body-area searches help discovery. They do not imply that evidence from one population, route or body site transfers to another.
Relevant compounds
Search all →
BPC-157
Primarily preclinical / extremely limited human evidence across injury and GI claims
TB-500
Direct preclinical evidence with confirmed human drug-exposure gap
BPC-157 + TB-500 blend
Blend — direct preclinical combination evidence; no human combination evidence
GHK-Cu
Topical/cosmetic human evidence is limited and mixed; injectable evidence limited
GHK-Cu + BPC-157 + TB-500 blend
Blend — no direct clinical evidence identified for the exact blend
KPV
Preclinical / human-cell mechanistic; no established human drug exposure
Long R3 IGF-1
Preclinical/biochemical evidence with human therapeutic-efficacy gap
Semaglutide (injectable)
STEP 9 studied adults with obesity and knee osteoarthritis and reported improvements in body weight and knee pain/function. This does not show direct tendon, ligament or cartilage repair.